Literature DB >> 16319281

ACOG Committee Opinion. Number 325, December 2005. Update on carrier screening for cystic fibrosis.

.   

Abstract

In 2001, the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis. The American College of Obstetricians and Gynecologists has updated current guidelines for cystic fibrosis screening practices among obstetrician-gynecologists.

Entities:  

Mesh：

Year:  2005        PMID： 16319281     DOI： 10.1097/00006250-200512000-00055

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


  23 in total

1.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

2.  Ethical, legal, and social issues in health technology assessment for prenatal/preconceptional and newborn screening: a workshop report.

Authors:  B K Potter; D Avard; V Entwistle; C Kennedy; P Chakraborty; M McGuire; B J Wilson
Journal:  Public Health Genomics       Date:  2008-09-03       Impact factor: 2.000

3.  Development of genomic reference materials for cystic fibrosis genetic testing.

Authors:  Victoria M Pratt; Michele Caggana; Christina Bridges; Arlene M Buller; Lisa DiAntonio; W Edward Highsmith; Leonard M Holtegaard; Kasinathan Muralidharan; Elizabeth M Rohlfs; Jack Tarleton; Lorraine Toji; Shannon D Barker; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2009-04-09       Impact factor: 5.568

4.  Identification of cystic fibrosis variants by polymerase chain reaction/oligonucleotide ligation assay.

Authors:  Karen M Schwartz; Lisa L Pike-Buchanan; Kasinathan Muralidharan; Joy B Redman; Jean Amos Wilson; Michael Jarvis; M Grace Cura; Victoria M Pratt
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

5.  Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.

Authors:  Elinor Langfelder-Schwind; Barbara Karczeski; Michelle N Strecker; Joy Redman; Elaine A Sugarman; Christina Zaleski; Trisha Brown; Steven Keiles; Amy Powers; Sumheda Ghate; Rebecca Darrah
Journal:  J Genet Couns       Date:  2013-09-07       Impact factor: 2.537

Review 6.  Genetic screening.

Authors:  Wylie Burke; Beth Tarini; Nancy A Press; James P Evans
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

7.  Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise.

Authors:  Mary Beth Brown; Karla K V Haack; Brian P Pollack; Mindy Millard-Stafford; Nael A McCarty
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-12       Impact factor: 3.619

8.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

9.  Patient physical characteristics and primary care physician decision making in preconception genetic screening.

Authors:  V L Bonham; S Knerr; W G Feero; N Stevens; J F Jenkins; C M McBride
Journal:  Public Health Genomics       Date:  2009-11-26       Impact factor: 2.000

Review 10.  Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management.

Authors:  Angela E Lin; Craig T Basson; Elizabeth Goldmuntz; Pilar L Magoulas; Deborah A McDermott; Donna M McDonald-McGinn; Elspeth McPherson; Colleen A Morris; Jacqueline Noonan; Catherine Nowak; Mary Ella Pierpont; Reed E Pyeritz; Alan F Rope; Elaine Zackai; Barbara R Pober
Journal:  Genet Med       Date:  2008-07       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.